These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 1659573)
1. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. Ossowski L; Clunie G; Masucci MT; Blasi F J Cell Biol; 1991 Nov; 115(4):1107-12. PubMed ID: 1659573 [TBL] [Abstract][Full Text] [Related]
2. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis. Zhu F; Jia S; Xing G; Gao L; Zhang L; He F DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166 [TBL] [Abstract][Full Text] [Related]
3. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding. Quax PH; Grimbergen JM; Lansink M; Bakker AH; Blatter MC; Belin D; van Hinsbergh VW; Verheijen JH Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826 [TBL] [Abstract][Full Text] [Related]
4. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. Olson D; Pöllänen J; Høyer-Hansen G; Rønne E; Sakaguchi K; Wun TC; Appella E; Danø K; Blasi F J Biol Chem; 1992 May; 267(13):9129-33. PubMed ID: 1315748 [TBL] [Abstract][Full Text] [Related]
6. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. Busso N; Masur SK; Lazega D; Waxman S; Ossowski L J Cell Biol; 1994 Jul; 126(1):259-70. PubMed ID: 7517943 [TBL] [Abstract][Full Text] [Related]
7. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase. Vines DJ; Lee SW; Dichek DA; Ellis V J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879 [TBL] [Abstract][Full Text] [Related]
8. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis]. Kobayashi H Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830 [TBL] [Abstract][Full Text] [Related]
9. Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87). Longstaff C; Merton RE; Fabregas P; Felez J Blood; 1999 Jun; 93(11):3839-46. PubMed ID: 10339491 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine). Petersen LC Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959 [TBL] [Abstract][Full Text] [Related]
11. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway. Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777 [TBL] [Abstract][Full Text] [Related]
12. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase. Ossowski L J Cell Biol; 1988 Dec; 107(6 Pt 1):2437-45. PubMed ID: 2848851 [TBL] [Abstract][Full Text] [Related]
13. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936 [TBL] [Abstract][Full Text] [Related]
14. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy. Kook YH; Adamski J; Zelent A; Ossowski L EMBO J; 1994 Sep; 13(17):3983-91. PubMed ID: 8076594 [TBL] [Abstract][Full Text] [Related]
15. Vitronectin binding to urokinase receptor in human breast cancer. Carriero MV; Del Vecchio S; Franco P; Potena MI; Chiaradonna F; Botti G; Stoppelli MP; Salvatore M Clin Cancer Res; 1997 Aug; 3(8):1299-308. PubMed ID: 9815812 [TBL] [Abstract][Full Text] [Related]
16. In vitro anti-proliferative and anti-invasive role of aminoterminal fragment of urokinase-type plasminogen activator on 8701-BC breast cancer cells. Luparello C; Del Rosso M Eur J Cancer; 1996 Apr; 32A(4):702-7. PubMed ID: 8695276 [TBL] [Abstract][Full Text] [Related]
17. Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function. Fischer K; Lutz V; Wilhelm O; Schmitt M; Graeff H; Heiss P; Nishiguchi T; Harbeck N; Kessler H; Luther T; Magdolen V; Reuning U FEBS Lett; 1998 Oct; 438(1-2):101-5. PubMed ID: 9821967 [TBL] [Abstract][Full Text] [Related]
18. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Stahl A; Mueller BM Cancer Res; 1994 Jun; 54(11):3066-71. PubMed ID: 8187097 [TBL] [Abstract][Full Text] [Related]
19. Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells. Wilhelm O; Weidle U; Höhl S; Rettenberger P; Schmitt M; Graeff H FEBS Lett; 1994 Jan; 337(2):131-4. PubMed ID: 8287966 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor. Mori T; Abe T; Wakabayashi Y; Hikawa T; Matsuo K; Yamada Y; Kuwano M; Hori S J Neurooncol; 2000; 46(2):115-23. PubMed ID: 10894364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]